Here are five highlights:
1. The patent covers the administration of any “spine deformation therapeutics to a patient having a spine deformation altered risk associated biomarker.”
2. This patent application’s claims boost Predictive Technology Group’s intellectual property.
3. This patent is additive to previous patents.
4. Predictive Technology Group also has other U.S. and international patent applications in the works.
5. The company develops and acquires proprietary technologies that address human disease and the role genes play.
More articles on devices:
SeaSpine, Orthofix, Amendia & more: 7 key notes
43 orthopedic, spine devices receive FDA 510(k) clearance in November 2016
Offering small orthopedic companies a competitive edge — Ortho Sales Partners’ purpose
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
